Boston Scientific Says PREVAIL Results Affirm Safety of Watchman LAA Anti-Stroke Device
This article was originally published in The Pink Sheet Daily
Executive Summary
Inexperienced users had similar results as experienced operators in the PREVAIL trial of Boston Scientific’s Watchman left-atrial appendage closure device. FDA asked the company to conduct the trial after results of the PROTECT AF trial left doubts about the device’s safety and steep learning curve.